SAVE THE DATE: Herantis Pharma to Host Virtual R&D Investor Day on Tuesday June 8, 2021
Herantis Pharma Plc, Company release, 28 April 2021 at 3:30 PM EEST Herantis Pharma Plc (“Herantis or the Company”), focusing on disease modifying therapies for debilitating neurodegenerative diseases, will host a virtual R&D Investor Day Tuesday 8 June, for investors, analysts and media, and other interested audiences. The event is intended to provide an update on the Company’s disease modifying assets Cerebral Dopamine Neurotrophic Factor CDNF and xCDNF, that focus on improving neuronal survival and stop the progression of Parkinson’s and other neurodegenerative diseases. External